FirstMerit Bank N.A. Trustee’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
$292K Hold
4,832
0.02% 270
2016
Q1
$272K Hold
4,832
0.02% 262
2015
Q4
$328K Buy
4,832
+229
+5% +$15K 0.03% 247
2015
Q3
$293K Buy
4,603
+200
+5% +$13.2K 0.03% 261
2015
Q2
$280K Hold
4,403
0.02% 274
2015
Q1
$301K Hold
4,403
0.02% 256
2014
Q4
$309K Hold
4,403
0.03% 253
2014
Q3
$315K Hold
4,403
0.03% 254
2014
Q2
$327K Hold
4,403
0.03% 249
2014
Q1
$286K Buy
4,403
+241
+6% +$15.6K 0.02% 261
2013
Q4
$247K Sell
4,162
-240
-5% -$13K 0.02% 264
2013
Q3
$229K Hold
4,402
0.02% 263
2013
Q2
$208K Buy
+4,402
New +$224K 0.02% 259

Other funds holding AZN

FirstMerit Bank N.A. Trustee's AZN Position: Q2 2016 in Review

FirstMerit Bank N.A. Trustee held its AstraZeneca (AZN) position steady in Q2 2016 at 4,832 shares worth $292K. The position accounts for 0.02% of the portfolio, ranked #270.

FirstMerit Bank N.A. Trustee first reported a position in AZN in Q2 2013 and has held it in 13 quarters since. The position peaked at $328K in Q4 2015. 398 funds tracked by Wall St. Rank hold AZN as of Q2 2016.

  • FirstMerit Bank N.A. Trustee held 4,832 shares of AstraZeneca worth $292K as of Q2 2016.
  • FirstMerit Bank N.A. Trustee left its AstraZeneca share count unchanged in Q2 2016.
  • AstraZeneca made up 0.02% of FirstMerit Bank N.A. Trustee's portfolio in Q2 2016, its #270 holding.
  • FirstMerit Bank N.A. Trustee first reported a position in AstraZeneca in Q2 2013 and has held it in 13 quarters since.
  • FirstMerit Bank N.A. Trustee's AstraZeneca position peaked at $328K in Q4 2015.
  • 398 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2016.

Based on FirstMerit Bank N.A. Trustee's 13F filing for Q2 2016, filed 11 Jul 2016.